SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001144204-12-017169
Filing Date
2012-03-26
Accepted
2012-03-26 17:06:59
Documents
7

Document Format Files

Seq Description Document Type Size
1 v307092_s1a.htm S-1/A 4269926
  Complete submission text file 0001144204-12-017169.txt   13204489

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT gnbt-20120131.xml EX-101.INS 1738617
3 XBRL TAXONOMY EXTENSION SCHEMA gnbt-20120131.xsd EX-101.SCH 147649
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnbt-20120131_cal.xml EX-101.CAL 52272
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnbt-20120131_def.xml EX-101.DEF 306897
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnbt-20120131_lab.xml EX-101.LAB 794178
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnbt-20120131_pre.xml EX-101.PRE 380482
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: S-1/A | Act: 33 | File No.: 333-180170 | Film No.: 12715049
SIC: 2834 Pharmaceutical Preparations